RECRUITING

Radiofrequency Ablation Study in LatinX Patients

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Benign thyroid nodules can still create cosmetic, compressive, or hormonal issues for patients. In the past, surgery was typically used to treat thyroid nodules causing the above issues through partial or complete thyroidectomy. More recently, minimally-invasive techniques have been developed to treat these issues. This study is investigating the use of one of these techniques, radiofrequency ablation, in Latinx patients with benign symptomatic thyroid nodules. This procedure is of interest because it avoids the risks of surgery and can be done outside an operating room. The study hypothesis is that the use of RFA is an effective and safe therapeutic option for LatinX patients with a symptomatic benign nodule wishing to avoid surgery.

Official Title

Study of the Use of Radiofrequency Ablation in LatinX Patients With Symptomatic Benign Thyroid Nodules

Quick Facts

Study Start:2024-03-12
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05903196

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subject capable of giving informed consent
  2. * Stated willingness to comply with all study procedures and availability for the duration of the study
  3. * Subjects over 18 years of age
  4. * Subject who self-identifies as LatinX
  5. * Subjects who have a benign, symptomatic thyroid nodule
  6. * Subjects whose nodule has well-defined margin on ultrasound and is surrounded by at least 2mm of normal thyroid parenchyma in all directions
  1. * Patients who are pregnant, trying to become pregnant, or breastfeeding
  2. * Patient who have a cardiac pacemaker,defibrillator , or other electromedical equipment
  3. * Patients who have a nodule that is malignant or not predominantly solid (must be \>50% solid by ultrasound)
  4. * Patients who cannot give consent
  5. * Patients on anticoagulation or dual antiplatelet therapy
  6. * Patients with acute illness
  7. * People with BP \> 140/90 prior to the scheduled procedure

Contacts and Locations

Study Contact

Karina Ziskovich, BBA
CONTACT
212-434-3715
kziskovich@northwell.edu
Jose Sanchez, MD
CONTACT
212-434-4972
jsanchez17@northwell.edu

Principal Investigator

Daniel Kuriloff, MD
PRINCIPAL_INVESTIGATOR
Northwell Health

Study Locations (Sites)

Northwell Health Physician Partners
New York, New York, 10022
United States

Collaborators and Investigators

Sponsor: Northwell Health

  • Daniel Kuriloff, MD, PRINCIPAL_INVESTIGATOR, Northwell Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-12
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2024-03-12
Study Completion Date2025-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Thyroid Nodule